LLY hits a historic $1T valuation as booming GLP-1 sales from Mounjaro and Zepbound drive growth and expand momentum across ...

Eli Lilly became the first healthcare company to hit a $1 trillion valuation (briefly on Nov. 21) MONDAY, Nov. 24, 2025 ...

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by ...

Eli Lilly stock has regained all-time highs, outpacing rivals in the obesity drug market. Click here to read my latest ...

Eli Lilly stock soars on obesity drug success. See here to know why LLY remains a top pick with strong growth prospects and a ...

If you're a growth-oriented investor looking for a no-brainer stock to buy with a rock-solid balance sheet and a track record ...

Eli Lilly LLY has been on an acquisition spree since the beginning of this year to bolster its pipeline, which should drive long-term growth. Although the cardiometabolic health space remains its core ...

Eli Lilly stock (NYSE: LLY) will report its Q3 results on Wednesday, October 30. The pharmaceutical giant is expected to garner $12.1 billion in sales and $1.45 in adjusted earnings per share, per the ...

Eli Lilly (LLY) is experiencing a banner year, as its stock price has reached new all-time highs in June. The surge comes on the heels of a series of positive developments for the pharmaceutical giant ...

Dodge & Cox, managed by John A. Gunn, recently executed a significant transaction involving Eli Lilly And Company (($LLY)).

Investments in AI have been gaining rapid momentum across industries, however 2025 is proving to be the year that it's taking off in the healthcare space. This has been accelerated by several huge ...

Drugmaker Eli Lilly is rolling out a new model to make it easier for employers to provide access to its GLP-1 drugs for ...